SRAX Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SRAX in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SRAX stock.
View analyst ratings for SRAX or view top-rated stocks.

1 analysts have issued 12-month target prices for SRAX's stock. Their SRAX stock forecasts range from $13.00 to $13.50. On average, they predict SRAX's stock price to reach $13.25 in the next year. This suggests a possible upside of 312.8% from the stock's current price.
View analysts' price targets for SRAX or view top-rated stocks among Wall Street analysts.

SRAX's stock was trading at $4.49 at the beginning of 2022. Since then, SRAX stock has decreased by 28.5% and is now trading at $3.21.
View the best growth stocks for 2022 here.

SRAX is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022.
View our earnings forecast for SRAX.

SRAX, Inc. (NASDAQ:SRAX) released its quarterly earnings data on Monday, June, 6th. The business services provider reported ($0.20) earnings per share (EPS) for the quarter. The business services provider earned $9.59 million during the quarter. SRAX had a negative net margin of 129.60% and a negative trailing twelve-month return on equity of 55.13%. During the same period in the previous year, the firm earned ($0.57) earnings per share.
View SRAX's earnings history.

SRAX shares split on the morning of Friday, September 17th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly created shares were distributed to shareholders after the market closes on Friday, September 17th 2021. An investor that had 100 shares of SRAX stock prior to the split would have 200 shares after the split.

SRAX issued an update on its first quarter 2022 earnings guidance on Monday, July, 4th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $11.50 million-$11.50 million, compared to the consensus revenue estimate of $11.50 million.

Some companies that are related to SRAX include Groupon (GRPN), M&C Saatchi (SAA), The Pebble Group (PEBB), EQ (EQ), XLMedia (XLM), The Mission Marketing Group (TMMG), Dianomi (DNM), The Mission Group (TMG), ad pepper media International (APM), Mirriad Advertising (MIRI), Snipp Interactive (SPN), AirNet Technology (ANTE), Starco Brands (STCB), Silver Bullet Data Services Group (SBDS) and Iconic Labs (ICON).
View all of SRAX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other SRAX investors own include TG Therapeutics (TGTX), Zynerba Pharmaceuticals (ZYNE), Lowe's Companies (LOW), Square (SQ), Skyworks Solutions (SWKS), TransEnterix (TRXC), Tesla (TSLA), Vuzix (VUZI), Wells Fargo & Company (WFC) and Advanced Micro Devices (AMD).

SRAX trades on the NASDAQ under the ticker symbol "SRAX."

Shares of SRAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SRAX stock can currently be purchased for approximately $3.21.

SRAX (NASDAQ:SRAX) has a market capitalization of $83.94 million and generates $28.55 million in revenue each year. The business services provider earns $-34,320,000.00 in net income (profit) each year or ($1.91) on an earnings per share basis.

SRAX employs 158 workers across the globe.

SRAX's mailing address is 456 SEATON STREET, LOS ANGELES CA, 90013. The official website for SRAX is www.srax.com. The business services provider can be reached via phone at (323) 694-9800 or via email at srax@lhai.com.